Delivery Order SPE2DB20D3103-SPE2DB24FP3W9

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,411.44 and an ultimate completion date of February 19, 2025. It covers the procurement of Cinacalcet HCl 30 mg tablets for federal government medical programs. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.40 firm fixed-price delivery order is for 4,567,394,905 units of CINACALCET HCL 30 MG TABLET 30S. The contract has a ceiling value of $5,524.40 and a completion date of February 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $17,150.74 firm fixed-price delivery order is for the provision of Calquence 100 mg tablets, a prescription medication. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,017.10 Firm Fixed Price Delivery Order contract is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,628.66 firm fixed price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,726.08, is for the delivery of Calquence 100 mg tablets over a period ending on November 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,096.72, is for the delivery of Candesartan Cilexetil 8 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 18, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $10,685.92, is for the delivery of Inlyta 5 mg tablets. The contract has no set-aside designation, indicating full and open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.35, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 26, 2025. The award covers the delivery of AMLOD-VALSA-HCTZ 10-160-25 MG 30S pharmaceutical products. This contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP3W9
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,878.75, is a Firm Fixed Price Delivery Order for the supply of Cinacalcet HCl 30 mg tablets. The contract has a period of performance through July 3, 2024 and is not designated as a set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:55 AM